This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Co-Design of a Digital Health Tool for Use by Individuals With Opioid Use Disorder: App4Independence (A4i-O).
Substance use & addiction journal · 2025
A computer-assisted telephone collaborative care intervention provided by lay providers for the treatment of comorbid depression and at-risk drinking: Analysis of a randomized controlled trial.
Journal of substance use and addiction treatment · 2024
Latest funding
- $100,000
The SWAGAT Study: Smoking cessation and Weight gain Attenuation with dual Glucagon like Peptide Receptor & Gastric Inhibitory Receptor Agonist- Tirzepatide: A double blinded RCT.
CIHR · 2026 · Co-investigator
- $1,468,800
A Phase II Multi-Site, Double-Blind, Randomized, Sham-Controlled, Clinical Trial of Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
CIHR · 2025 · Co-investigator
- $952,425
Semaglutide as a Treatment for Cannabis Use Disorder: A Randomized Controlled Trial
CIHR · 2025 · Nominated PI
2 publications.
Co-Design of a Digital Health Tool for Use by Individuals With Opioid Use Disorder: App4Independence (A4i-O).
D'Arcey JN, Tackaberry-Giddens L, Junaid S, Zhou W, Quilty L, Sloan M, Kidd SA
A computer-assisted telephone collaborative care intervention provided by lay providers for the treatment of comorbid depression and at-risk drinking: Analysis of a randomized controlled trial.
Kim HK, Melamed OC, Sloan M, Husain MI, Rodie DJ, Perivolaris A, Kurdyak P, Oslin DW, Geist R, Selby P, Mulsant BH, PARTNERs Study Group
The SWAGAT Study: Smoking cessation and Weight gain Attenuation with dual Glucagon like Peptide Receptor & Gastric Inhibitory Receptor Agonist- Tirzepatide: A double blinded RCT.
Principal investigators: Selby, Peter L; Agarwal, Sri Mahavir; Melamed, Osnat; Mir, Hassan; Patton, Ian T; Tang, Victor M; Veldhuizen, Scott R; Zawertailo, Laurie A
Keywords: Addiction; Cardiometabolic Risk; Gastric Inhibitory Peptide; Glucagon-Like Peptide-1 Receptor Agonist; Nicotine Dependence; Obesity; Overweight; Smoking Cessation; Tobacco Use Disorder; Trizepatide
A Phase II Multi-Site, Double-Blind, Randomized, Sham-Controlled, Clinical Trial of Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
Principal investigators: Tang, Victor M; Blumberger, Daniel M; MacKillop, James
Keywords: Addiction; Cannabis; Cannabis Use Disorder; Neuromodulation; Transcranial Magnetic Stimulation
Semaglutide as a Treatment for Cannabis Use Disorder: A Randomized Controlled Trial
Principal investigators: Sloan, Matthew E; Hendershot, Christian S
Keywords: Cannabis Use Disorder; Randomized Controlled Trial; Semaglutide
Evaluating the Safety and Effectiveness of Novel Opioid Agonist Therapy Prescribing Practices
Principal investigators: Bozinoff, Nikki; Gomes, Tara
Keywords: Buprenorphine; Methadone; Opioid Agonist Therapy; Opioid Use Disorder; Pharmacoepidemiology; Treatment
Fatty Acid Amide Hydrolase in Brain of Youth With High-risk Alcohol Use: Positron Emission Tomography Studies With [11C]CURB
Principal investigators: Boileau, Isabelle; Hendershot, Christian S
Keywords: Alcohol Use Disorder; Endocannabinoid System; Fatty Acid Amide Hydrolase; Heavy Drinking; Positron Emission Tomography; Youth
Self-titration of high THC cannabis concentrates: a randomized crossover trial
Principal investigators: Rueda, Sergio; Bidwell, Cinnamon; Tang, Victor M
Keywords: Cannabis; Concentrates; Randomized Crossover Trial; Thc Titration
Cognitive Interventions for Substance Use Disorder: Identifying Research Priorities
Principal investigators: Quilty, Lena C
Keywords: Cognition; Cognitive Intervention; Engagement; Integrated Knowledge Translation; Substance Use Disorder
Integrating Transcranial Magnetic Stimulation as a Treatment for Nicotine Dependence in the Clinic: A Pragmatic, Hybrid Effectiveness-Implementation Trial.
Principal investigators: Tang, Victor M; Buckley, Leslie; Robinson, Lee M; Selby, Peter L; Sloan, Matthew E
Keywords: Brain Stimulation; Clinical Trial; Comparative Effectiveness; Implementation Science; Smoking; Therapeutic
Pilot Clinical Study: Psilocybin Assisted Psychotherapy as a Novel Treatment for Comorbid Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD).
Principal investigators: Le Foll, Bernard
Keywords: Alcohol Use Disorder; Clinical Trial; Major Depressive Disorder; Mental Health; Neuroscience; Pharmacology; Psychedelics; Psychiatry; Therapy; Treatment
Intensive Virtual Treatment with Remote Abstinence Monitoring for Alcohol Use Disorder
Principal investigators: Sloan, Matthew E; Buckley, Leslie
Keywords: Alcohol Use Disorder; Telemedicine
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Psychiatry
- Department of Family and Community Medicine
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.